University of Melbourne
Department of Obstetrics and Gynaecology
Professor Suzanne Garland, AO, MBBS, MD, FRCPA, FRANZCOG Ad Eundem, FAChSHM, FASM, FACOG Hons Prof Suzanne Garland AO is a Clinical Microbiologist and Sexual Health Physician who has worked on HPV from epidemiology, clinical HPV vaccine trials for the bivalent and quadrivalent vaccines, and vaccine effectiveness post HPV vaccine rollout in the National Immunisation Program in Australia. She is a member of the WHO HPV Working Group to SAGE. She was a founding member of the Society Asia Oceania Research Organisation on Genital Infections and Neoplasia (AOGIN), almost 20 years ago and is the Inaugural and Past President of AOGIN and ongoing Board Advisor. She has ~ 800 peer reviewed articles in the scientific literature. She is President IPVS, Chair of IPVS Policy Committee. In 2018 she was a recipient of an Officer of the Order of Australia, AO, for distinguished service to medicine especially infectious disease research as a physician, researcher, and to professional medical organisations and in 2019 an Honorary FACOG.

Moderator of 5 Sessions

Session Type
Interdisciplinary Workshop
Date
Mon, Apr 17, 2023
Session Time
08:00 AM - 09:30 AM
Room
Ballroom C
Session Type
Special Satellite Symposium
Date
Tue, Apr 18, 2023
Session Time
07:15 AM - 08:15 AM
Room
207B
Session Description
The global HPV laboratory network (LabNet) was organized by the WHO in 2007 to promote the quality-assured laboratory services required for HPV DNA and antibody detection. A large number of countries officially appointed National HPV Reference Laboratories (NRL) and in 2021 the Global Network of National HPV Reference Laboratories was formed to continue promoting the quality-assured HPV testing services that will be required for optimal HPV and cervical cancer elimination strategies. The purpose of this satellite symposium with participation of NRLs from Australia, Japan, Turkey, Belgium, France, Germany, Scotland, Slovenia, South Africa, Sweden, Norway, USA, and Argentina is to report on activities and exchange scientific and practical information. The tentative topics are: (1) NRL re-analysis of HPV-negative high-grade cervical lesions as a means to further testing quality; (2) key performance indicators for HPV-based screening (3) joint resources for furthering HPV testing quality: global proficiency panels; E-learning resources and (4) role of reference laboratories to further HPV elimination. The symposium is open to all laboratories interested in HPV testing, with the hope that the support from the NRLs can be increasingly effective for contributing to advancement of HPV testing services.
Session Type
Plenary Session
Date
Tue, Apr 18, 2023
Session Time
04:30 PM - 06:00 PM
Room
Ballroom C
Session Type
Plenary Session
Date
Wed, Apr 19, 2023
Session Time
11:00 AM - 12:30 PM
Room
Ballroom C
Session Type
Plenary Session
Date
Fri, Apr 21, 2023
Session Time
04:00 PM - 05:15 PM
Room
Ballroom C

Presenter of 3 Presentations

ROLE OF A REFERENCE LABORATORY TO FURTHER HPV ELIMINATION

Session Type
Special Satellite Symposium
Date
Tue, Apr 18, 2023
Session Time
07:15 AM - 08:15 AM
Room
207B
Presentation Type
ONSITE
Lecture Time
07:15 AM - 07:27 AM

WELCOME

Session Type
Special Satellite Symposium
Date
Wed, Apr 19, 2023
Session Time
09:45 AM - 10:45 AM
Room
206
Presentation Type
ONSITE
Lecture Time
09:45 AM - 09:57 AM

INTRODUCTION TO HPV VACCINE MONITORING

Session Type
Special Satellite Symposium
Date
Wed, Apr 19, 2023
Session Time
05:15 PM - 06:45 PM
Room
207A
Presentation Type
ONSITE
Lecture Time
05:15 PM - 05:20 PM